BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 8041115)

  • 1. On the analysis of the pathophysiology of Chediak-Higashi syndrome. Defects expressed by cultured melanocytes.
    Zhao H; Boissy YL; Abdel-Malek Z; King RA; Nordlund JJ; Boissy RE
    Lab Invest; 1994 Jul; 71(1):25-34. PubMed ID: 8041115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered protein localization in melanocytes from Hermansky-Pudlak syndrome: support for the role of the HPS gene product in intracellular trafficking.
    Boissy RE; Zhao Y; Gahl WA
    Lab Invest; 1998 Sep; 78(9):1037-48. PubMed ID: 9759648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, molecular, and cell biological aspects of Chediak-Higashi syndrome.
    Introne W; Boissy RE; Gahl WA
    Mol Genet Metab; 1999 Oct; 68(2):283-303. PubMed ID: 10527680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing between the catalytic potential and apparent expression of tyrosinase activities.
    Zhao H; Boissy RE
    Am J Med Sci; 1994 Dec; 308(6):322-30. PubMed ID: 7985719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mislocalization of melanosomal proteins in melanocytes from mice with oculocutaneous albinism type 2.
    Manga P; Boissy RE; Pifko-Hirst S; Zhou BK; Orlow SJ
    Exp Eye Res; 2001 Jun; 72(6):695-710. PubMed ID: 11384158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosinase processing and intracellular trafficking is disrupted in mouse primary melanocytes carrying the underwhite (uw) mutation. A model for oculocutaneous albinism (OCA) type 4.
    Costin GE; Valencia JC; Vieira WD; Lamoreux ML; Hearing VJ
    J Cell Sci; 2003 Aug; 116(Pt 15):3203-12. PubMed ID: 12829739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of the lesions in cultured fibroblasts of humans and four species of animals with Chediak-Higashi syndrome.
    Penner JD; Prieur DJ
    Am J Med Genet; 1987 Oct; 28(2):445-54. PubMed ID: 3425619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal tyrosine transport and abnormal tyrosinase routing in pink-eyed dilution melanocytes.
    Potterf SB; Furumura M; Sviderskaya EV; Santis C; Bennett DC; Hearing VJ
    Exp Cell Res; 1998 Oct; 244(1):319-26. PubMed ID: 9770375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpesvirus saimiri-transformed CD8+ T cells as a tool to study Chediak-Higashi syndrome cytolytic lymphocytes.
    Martín-Fernández JM; Cabanillas JA; Rivero-Carmena M; Lacasa E; Pardo J; Anel A; Ramírez-Duque PR; Merino F; Rodríguez-Gallego C; Regueiro JR
    J Leukoc Biol; 2005 May; 77(5):661-8. PubMed ID: 15728247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-regulation of melanin precursors and tyrosinase in human pigment cells: roles of cysteine and glutathione.
    Benathan M; Virador V; Furumura M; Kobayashi N; Panizzon RG; Hearing VJ
    Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):981-90. PubMed ID: 10644002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of melanocyte stimulating hormone on human cultured choroidal melanocytes, uveal melanoma cells, and retinal epithelial cells.
    Goodall T; Buffey JA; Rennie IG; Benson M; Parsons MA; Faulkner MK; MacNeil S
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):826-37. PubMed ID: 8125745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysosome enlargement in the Chediak-Higashi syndrome.
    Spicer SS; Sato A; Vincent R; Eguchi M; Poon KC
    Fed Proc; 1981 Apr; 40(5):1451-5. PubMed ID: 7215561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Origin of melanosome structures and cytochemical localizations of tyrosinase activity in differentiating epidermal melanocytes of newborn mouse skin.
    Hirobe T
    J Exp Zool; 1982 Dec; 224(3):355-63. PubMed ID: 6818322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanocytes derived from patients with Hermansky-Pudlak Syndrome types 1, 2, and 3 have distinct defects in cargo trafficking.
    Richmond B; Huizing M; Knapp J; Koshoffer A; Zhao Y; Gahl WA; Boissy RE
    J Invest Dermatol; 2005 Feb; 124(2):420-7. PubMed ID: 15675963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosinase-related proteins suppress tyrosinase-mediated cell death of melanocytes and melanoma cells.
    Rad HH; Yamashita T; Jin HY; Hirosaki K; Wakamatsu K; Ito S; Jimbow K
    Exp Cell Res; 2004 Aug; 298(2):317-28. PubMed ID: 15265682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chediak-Higashi syndrome. Expression of the cytoplasmic defect by in vitro cultures of bone marrow progenitors.
    Barak Y; Karov Y; Nir E; Wagner Y; Kristal H; Levin S
    Am J Pediatr Hematol Oncol; 1986; 8(2):128-33. PubMed ID: 3740366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysosomal enzyme activities in Chediak-Higashi syndrome: evaluation of lymphoblastoid cell lines and review of the literature.
    Holcombe RF; Jones KL; Stewart RM
    Immunodeficiency; 1994; 5(2):131-40. PubMed ID: 8032365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hermansky-Pudlak syndrome and Chediak-Higashi syndrome: disorders of vesicle formation and trafficking.
    Huizing M; Anikster Y; Gahl WA
    Thromb Haemost; 2001 Jul; 86(1):233-45. PubMed ID: 11487012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular melanin pigmentation anomalies in cats, cattle, mink, and mice with Chediak-Higashi syndrome: histologic observations.
    Collier LL; Prieur DJ; King EJ
    Curr Eye Res; 1984 Oct; 3(10):1241-51. PubMed ID: 6488853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinico-hematological profile of Chediak-Higashi syndrome: experience from a tertiary care center in south India.
    Roy A; Kar R; Basu D; Srivani S; Badhe BA
    Indian J Pathol Microbiol; 2011; 54(3):547-51. PubMed ID: 21934218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.